高雄醫學大學圖書館 |

Pancreatic Cancer Risk After Chronic Hepatitis C Virus Infection: A National, Population-Based Study /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Pancreatic Cancer Risk After Chronic Hepatitis C Virus Infection: A National, Population-Based Study // Rachel Levinson.
Author:	Levinson, Rachel,
Description:	1 electronic resource (57 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 86-11, Section: B.
基督教聖經之智慧書導讀 :	Studies of the association of hepatitis C virus (HCV), a known oncovirus, and pancreatic ductal adenocarcinoma (PDAC) are limited. We aimed to assess the relationship between chronic HCV infection, HCV genotype, and PDAC. In this retrospective cohort study, we identified individuals in the Veterans Health Administration from 2001 to 2021 with HCV testing. We categorized HCV status as those without HCV, those exposed (without chronic infection), or those with chronic infection. We evaluated incident PDAC by HCV status using Cox proportional hazards regression, adjusting for pertinent confounders. We further investigated the association between HCV genotype and risk of PDAC. Of 6.3 million people tested for HCV, 3.9% (n=246,218) had chronic HCV and 3.3% (n=209,492) were exposed. There were 33,451 cases of incident PDAC. Compared to people without HCV, chronic HCV infection (HR 1.76, 95% CI 1.67-1.86) and HCV exposure (HR 1.18, 95% CI 1.11-1.25) were associated with increased risk of incident PDAC, adjusting for demographic and clinical confounders. Among HCV genotypes, genotype 1 was associated with the highest PDAC risk (HR 1.81, 95% CI 1.68-1.94) compared to those without HCV. Among Veterans, chronic HCV infection is associated with a 1.8-fold higher risk of PDAC diagnosis and HCV genotype 1 was associated with the highest PDAC risk. These findings prompt future research on the mechanisms underlying this association and the impact of HCV treatment on PDAC risk.
Contained By:	Dissertations Abstracts International86-11B.
Subject:	Oncology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31930925
ISBN:	9798314887127

Pancreatic Cancer Risk After Chronic Hepatitis C Virus Infection: A National, Population-Based Study /
Levinson, Rachel,

Pancreatic Cancer Risk After Chronic Hepatitis C Virus Infection: A National, Population-Based Study /Rachel Levinson. - 1 electronic resource (57 pages)

Source: Dissertations Abstracts International, Volume: 86-11, Section: B.

Studies of the association of hepatitis C virus (HCV), a known oncovirus, and pancreatic ductal adenocarcinoma (PDAC) are limited. We aimed to assess the relationship between chronic HCV infection, HCV genotype, and PDAC. In this retrospective cohort study, we identified individuals in the Veterans Health Administration from 2001 to 2021 with HCV testing. We categorized HCV status as those without HCV, those exposed (without chronic infection), or those with chronic infection. We evaluated incident PDAC by HCV status using Cox proportional hazards regression, adjusting for pertinent confounders. We further investigated the association between HCV genotype and risk of PDAC. Of 6.3 million people tested for HCV, 3.9% (n=246,218) had chronic HCV and 3.3% (n=209,492) were exposed. There were 33,451 cases of incident PDAC. Compared to people without HCV, chronic HCV infection (HR 1.76, 95% CI 1.67-1.86) and HCV exposure (HR 1.18, 95% CI 1.11-1.25) were associated with increased risk of incident PDAC, adjusting for demographic and clinical confounders. Among HCV genotypes, genotype 1 was associated with the highest PDAC risk (HR 1.81, 95% CI 1.68-1.94) compared to those without HCV. Among Veterans, chronic HCV infection is associated with a 1.8-fold higher risk of PDAC diagnosis and HCV genotype 1 was associated with the highest PDAC risk. These findings prompt future research on the mechanisms underlying this association and the impact of HCV treatment on PDAC risk.

English

ISBN: 9798314887127Subjects--Topical Terms:

273823
Oncology.
Subjects--Index Terms:

Genotype

Pancreatic Cancer Risk After Chronic Hepatitis C Virus Infection: A National, Population-Based Study /
LDR:03009nam a22004453i 4500 001 391484
005 20251124054805.5
006 m o d
007 cr|nu||||||||
008 251208s2025 miu||||||m |||||||eng d
020 $a 9798314887127
035 $a (MiAaPQD)AAI31930925
035 $a AAI31930925
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Levinson, Rachel, $e author. $3 524036
245 1 0 $a Pancreatic Cancer Risk After Chronic Hepatitis C Virus Infection: A National, Population-Based Study / $c Rachel Levinson.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (57 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-11, Section: B.
500 $a Advisors: Wang, Louise Committee members: Schuster, Kevin; Ketwaroo, Gyanprakash.
502 $b M.D. $c Yale University $d 2025.
520 $a Studies of the association of hepatitis C virus (HCV), a known oncovirus, and pancreatic ductal adenocarcinoma (PDAC) are limited. We aimed to assess the relationship between chronic HCV infection, HCV genotype, and PDAC. In this retrospective cohort study, we identified individuals in the Veterans Health Administration from 2001 to 2021 with HCV testing. We categorized HCV status as those without HCV, those exposed (without chronic infection), or those with chronic infection. We evaluated incident PDAC by HCV status using Cox proportional hazards regression, adjusting for pertinent confounders. We further investigated the association between HCV genotype and risk of PDAC. Of 6.3 million people tested for HCV, 3.9% (n=246,218) had chronic HCV and 3.3% (n=209,492) were exposed. There were 33,451 cases of incident PDAC. Compared to people without HCV, chronic HCV infection (HR 1.76, 95% CI 1.67-1.86) and HCV exposure (HR 1.18, 95% CI 1.11-1.25) were associated with increased risk of incident PDAC, adjusting for demographic and clinical confounders. Among HCV genotypes, genotype 1 was associated with the highest PDAC risk (HR 1.81, 95% CI 1.68-1.94) compared to those without HCV. Among Veterans, chronic HCV infection is associated with a 1.8-fold higher risk of PDAC diagnosis and HCV genotype 1 was associated with the highest PDAC risk. These findings prompt future research on the mechanisms underlying this association and the impact of HCV treatment on PDAC risk.
546 $a English
590 $a School code: 0265
650 4 $2 96060 $a Oncology. $3 273823
650 4 $2 96060 $a Epidemiology. $3 215933
650 4 $a Health sciences. $3 523815
653 $a Genotype
653 $a Hepatitis C virus
653 $a Pancreatic cancer
653 $a Pancreatic ductal adenocarcinoma
653 $a Risk
653 $a Veterans Health Administration
690 $a 0566
690 $a 0766
690 $a 0992
710 2 $a Yale University. $b Yale School of Medicine. $e degree granting institution. $3 524037
720 1 $a Wang, Louise $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-11B.
790 $a 0265
791 $a M.D.
792 $a 2025
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31930925